Titel

Merkliste
1 Ergebnisse

Tixagevimab–cilgavimab for treatment of patients hospitalis..:

Ginde, AA ; Paredes, R ; Murray, TA...
https://discovery.ucl.ac.uk/id/eprint/10161687/1/Tixagevimab%20cilgavimab%20for%20treatment%20of%20patients%20hospitalised%20with%20COVID%2019.pdf. , 2022

Link: https://discovery.ucl.ac.uk/id/eprint/10161687/1/Tixag..

RT Journal
T1 <Title>Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:10161687&Exemplar=1&LAN=DE
				
A1 Ginde, AA
A1 Paredes, R
A1 Murray, TA
A1 Engen, N
A1 Grandits, G
A1 Vekstein, A
A1 Ivey, N
A1 Mourad, A
A1 Sandkovsky, U
A1 Gottlieb, RL
A1 Berhe, M
A1 Jain, MK
A1 Marines-Price, R
A1 Agbor Agbor, BT
A1 Mateu, L
A1 España-Cueto, S
A1 Lladós, G
A1 Mylonakis, E
A1 Rogers, R
A1 Shehadeh, F
A1 Filbin, MR
A1 Hibbert, KA
A1 Kim, K
A1 Tran, T
A1 Morris, PE
A1 Cassity, EP
A1 Trautner, B
A1 Pandit, LM
A1 Knowlton, KU
A1 Leither, L
A1 Matthay, MA
A1 Rogers, AJ
A1 Drake, W
A1 Jones, B
A1 Poulakou, G
A1 Syrigos, KN
A1 Fernández-Cruz, E
A1 Natale, MD
A1 Almasri, E
A1 Balerdi-Sarasola, L
A1 Bhagani, SR
A1 Boyle, KL
A1 Casey, JD
A1 Chen, P
A1 Douin, DJ
A1 Files, DC
A1 Günthard, HF
A1 Hite, RD
A1 Hyzy, RC
A1 Khan, A
A1 Kibirige, M
A1 Kidega, R
A1 Kiweewa, F
A1 Jensen, JU
A1 Leshnower, BG
A1 Lutaakome, JK
A1 Manian, P
A1 Menon, V
A1 Morales-Rull, JL
A1 O'Mahony, DS
A1 Overcash, JS
A1 Ramachandruni, S
A1 Steingrub, JS
A1 Taha, HS
A1 Waters, M
A1 Young, BE
A1 Phillips, AN
A1 Murray, DD
A1 Jensen, TO
A1 Padilla, ML
A1 Sahner, D
A1 Shaw-Saliba, K
A1 Dewar, RL
A1 Teitelbaum, M
A1 Natarajan, V
A1 Rehman, MT
A1 Pett, S
A1 Hudson, F
A1 Touloumi, G
A1 Brown, SM
A1 Self, WH
A1 Chang, CC
A1 Sánchez, A
A1 Weintrob, AC
A1 Hatlen, T
A1 Grund, B
A1 Sharma, S
A1 Reilly, CS
A1 Garbes, P
A1 Esser, MT
A1 Templeton, A
A1 Babiker, AG
A1 Davey, VJ
A1 Gelijns, AC
A1 Higgs, ES
A1 Kan, V
A1 Matthews, G
A1 Thompson, BT
A1 Neaton, JD
A1 Lane, HC
PB Elsevier BV
YR 2022
K1 Adult
K1 Antibodies
K1 Monoclonal
K1 Neutralizing
K1 COVID-19
K1 Double-Blind Method
K1 Humans
K1 Treatment Outcome
JF https://discovery.ucl.ac.uk/id/eprint/10161687/1/Tixagevimab%20cilgavimab%20for%20treatment%20of%20patients%20hospitalised%20with%20COVID%2019.pdf
LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/10161687/1/Tixagevimab%20cilgavimab%20for%20treatment%20of%20patients%20hospitalised%20with%20COVID%2019.pdf
DO https://discovery.ucl.ac.uk/id/eprint/10161687/1/Tixagevimab%20cilgavimab%20for%20treatment%20of%20patients%20hospitalised%20with%20COVID%2019.pdf
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)